# The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020, Regulation 21: Applications involving temporary relocation

Extent: E+W

(1) A Local Health Board may make a temporary amendment to an entry in a pharmaceutical list by granting an application made by a person under regulation 15(1)(b)(ii) (applications to be included in or make amendment to a pharmaceutical list) to relocate to different premises on a temporary basis if it is satisfied that—
(a) the circumstances in which the application is made require the flexible provision of pharmaceutical services,
(b) for the patients who are accustomed to accessing pharmaceutical services at the existing premises, the location of the temporary premises is not significantly less accessible,
(c) the same pharmaceutical services will be provided at the temporary premises as are provided at the listed premises, and
(d) the provision of pharmaceutical services will not be interrupted (except for such period as the Local Health Board may for good cause allow).
(2) A temporary amendment to an entry in the pharmaceutical list will have effect from the date on which the Local Health Board approved the application made to it and will be valid for such period of up to 6 months and any further periods of up to 3 months each that the Local Health Board considers necessary.
(3) A person may revert to the overridden entry in the pharmaceutical list maintained by the Local Health Board before the end of the period determined by the Local Health Board under paragraph (2) on giving the Local Health Board at least 7 days’ notice in writing.
(4) Where, in accordance with this regulation, an entry in a pharmaceutical list is overridden by a temporary amendment, any proceedings with regard to the overridden arrangements are unaffected by that overriding (although they may need to be stayed for other reasons) and if, as a result of those proceedings the overridden arrangements require amendment before the end of the temporary amendment, the reversion to the overridden arrangements is to be to the original overridden amendments as amended as a result of those proceedings.

---
Source: https://www.legislation.gov.uk/wsi/2020/1073/regulation/21 (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/regulation-21
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.